Rare diseases
Investigational molecules
Locations
Back to Poland1 013 clinical trials in Lodz, Poland across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis
PolandStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
PolandStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
PolandStudy on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
PolandStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
PolandStudy of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
PolandStudy on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides
PolandStudy on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis
PolandStudy on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia
PolandStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
PolandStudy on Ublituximab for Patients with Relapsing Multiple Sclerosis
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on respiratory viral infections and preventive vaccines, particularly targeting RSV and influenza in older adults. Studies evaluate vaccine efficacy and immune responses to protect against severe respiratory diseases.
Multiple studies assess combination vaccines and co-administration strategies to enhance protection against multiple respiratory pathogens.
Innovative research examining treatments for plaque psoriasis and related conditions. Trials investigate novel therapeutic approaches including oral medications and biological treatments for moderate to severe cases.
Studies focus on measuring improvement in disease severity and quality of life outcomes for patients.
Comprehensive research on meningococcal and pneumococcal vaccines, with special attention to pediatric populations. Studies evaluate safety profiles and immune responses across different age groups.
Trials incorporate multiple age cohorts from infants to adolescents, ensuring comprehensive vaccine effectiveness data.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
